Page last updated: 2024-09-03

y 27632 and arsenic trioxide

y 27632 has been researched along with arsenic trioxide in 1 studies

Compound Research Comparison

Studies (y 27632)	Trials (y 27632)	Recent Studies (post-2010) (y 27632)	Studies (arsenic trioxide)	Trials (arsenic trioxide)	Recent Studies (post-2010) (arsenic trioxide)
1,924	3	891	3,119	160	1,507

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aki, T; Bessho, M; Funakoshi, T; Kato, C; Noritake, K; Uemura, K; Unuma, K	1

Other Studies

1 other study(ies) available for y 27632 and arsenic trioxide

Article	Year
Rho-kinase inhibitor Y-27632 attenuates arsenic trioxide toxicity in H9c2 cardiomyoblastoma cells. Cardiovascular toxicology, 2013, Volume: 13, Issue:3 Topics: Amides; Animals; Animals, Newborn; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Blotting, Western; Cardiotonic Agents; Caspases; Cell Line, Tumor; Cell Survival; Enzyme Activation; Enzyme Inhibitors; Genetic Vectors; Oxides; Pyridines; Rats; Reactive Oxygen Species; rho-Associated Kinases; Transfection; Vimentin	2013

Article

Year

Rho-kinase inhibitor Y-27632 attenuates arsenic trioxide toxicity in H9c2 cardiomyoblastoma cells.

Cardiovascular toxicology, 2013, Volume: 13, Issue:3

Topics: Amides; Animals; Animals, Newborn; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Blotting, Western; Cardiotonic Agents; Caspases; Cell Line, Tumor; Cell Survival; Enzyme Activation; Enzyme Inhibitors; Genetic Vectors; Oxides; Pyridines; Rats; Reactive Oxygen Species; rho-Associated Kinases; Transfection; Vimentin

2013